leisure time -WSS

leisure time

author：knowledge 2025-10-02 19:20:26 - browse：64888

Amid the stunning rebuke Amgen suffered at the hands of the U.S. Food and Drug Administration this week lurk numerous questions. And one of them may be whether the company was fully forthcoming about a pricey lung cancer drug that is supposed to generate key revenue growth.

At issue is a trial that Amgen is relying upon to win final approval for Lumakras, which the FDA approved on a conditional basis in 2021. This process, known as accelerated approval, required the company to run a confirmatory study. But ahead of an advisory panel meeting on Thursday, the agency released documents showing its staff found “potential systemic bias” in the trial.

The disclosure throws into question the future of this drug, which has offered hope to patients for whom an effective treatment previously seemed out of reach. Some Wall Street analysts are now betting the FDA will ask Amgen to run yet another trial or maybe withdraw the drug altogether. Either way, the prognosticators are reworking their calculus for Amgen stock.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Prosecutors say FTX founder Sam Bankman

WSS

New chart reveals military’s vast involvement in Operation Warp Speed

Kansas bar where gunfire wounded 9 last month closes permanently

What is artificial intelligence? Experts weigh in

With heat waves through August, officials warn of health risks

Kansas bar where gunfire wounded 9 last month closes permanently

Biden White House, tech companies launch new safeguards around emerging AI technology

focus

leisure time

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

Many breast cancer patients receive more radiation than needed

State Dept. review finds Biden bears some blame for Afghanistan failures

Failure, not just success, should guide future doctors

Wildfire smoke exposes gaps in outdoor worker protections

Why Marc Tessier

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Alkermes shareholders re

Hey, doctors: Don't be no

Wikipedia

How CRISPR works, explained in two minutes

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Trump used to be more articulate. What could explain the change?

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

focus

hotspot

entertainment

leisure time